Dominic P. Behan

2015

In 2015, Dominic P. Behan earned a total compensation of $1.6M as Former Executive Vice President, Chief Scientific Officer and Director at Arena Pharmaceuticals, a 16% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$111,827
Option Awards$381,930
Salary$456,435
Stock Awards$607,500
Other$16,710
Total$1,574,402

Behan received $607.5K in stock awards, accounting for 39% of the total pay in 2015.

Behan also received $111.8K in non-equity incentive plan, $381.9K in option awards, $456.4K in salary and $16.7K in other compensation.

Rankings

In 2015, Dominic P. Behan's compensation ranked 5,742nd out of 13,638 executives tracked by ExecPay. In other words, Behan earned more than 57.9% of executives.

ClassificationRankingPercentile
All
5,742
out of 13,638
58th
Division
Manufacturing
2,143
out of 5,190
59th
Major group
Chemicals And Allied Products
771
out of 1,854
58th
Industry group
Drugs
612
out of 1,528
60th
Industry
Pharmaceutical Preparations
481
out of 1,182
59th
Source: SEC filing on April 28, 2017.

Behan's colleagues

We found six more compensation records of executives who worked with Dominic P. Behan at Arena Pharmaceuticals in 2015.

2015

Jack Lief

Arena Pharmaceuticals

Chief Executive Officer

2015

Steven Spector

Arena Pharmaceuticals

General Counsel

2015

William Shanahan

Arena Pharmaceuticals

Chief Medical Officer

2015

Craig Audet

Arena Pharmaceuticals

Former Senior Vice President, Operations and Head of Global Regulatory Affairs

2015

Robert Hoffman

Arena Pharmaceuticals

Chief Financial Officer

2015

Harry Hixson

Arena Pharmaceuticals

Chief Executive Officer

You may also like